Kane Biotech is a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms.

Biofilms develop when bacteria and other microorganisms form a protective matrix that act as a shield against attacks. When in a biofilm, bacteria become highly resistant to antibiotics, biocides, disinfectants, high temperatures and host immune responses. This resiliency contributes to human health problems, such as tooth decay or medical device- and wound-associated infections.

Kane Biotech uses patent-protected technologies that are based on molecular mechanisms of biofilm formation/dispersal for finding compounds that inhibit or disrupt biofilms. The company has evidence these technologies have potential to significantly improve the ability to prevent, and/or destroy, biofilms in several medical and industrial applications.